Stem loop binding protein promotes SARS-CoV-2 replication via -1 programmed ribosomal frameshifting.

Publication date: Jun 13, 2025

The -1 programmed ribosomal frameshifting (-1 PRF) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for keeping the balance between pp1a and pp1ab polyproteins. To date, the host factors influencing this process remain poorly understood. Using RNA pull-down assays combined with mass spectrometry screening, we discovered five host proteins interacting with -1 PRF RNA, including Stem Loop Binding Protein (SLBP). Our findings revealed that SLBP overexpression enhanced frameshifting and promoted viral replication. Moreover, the interaction between SLBP and -1 PRF RNA was predicted using the PrismNet deep learning tool, which calculated a high binding probability of 0. 922. Using Electrophoretic Mobility Shift Assays (EMSAs) and RNA pull down assays, our findings demonstrated SLBP’s direct binding to the SARS-CoV-2 genome, with preferential affinity for the stem loop 3 region of the -1 PRF RNA. Using smFISH assays, we further confirmed their physical colocalization. The role of SLBP in promoting frameshifting was verified using an in vitro translation system. Further investigation showed that SLBP deletions reshaped the host factor pattern around -1 PRF RNA, diminishing interactions with FUBP3 and RPS3A while enhancing RPL10A binding. Together, our findings identify SLBP as a host protein that promotes SARS-CoV-2 frameshifting, highlighting its potential as a druggable target for COVID-19.

Open Access PDF

Concepts Keywords
Coronavirus COVID-19
Overexpression Frameshifting, Ribosomal
Ribosomal HEK293 Cells
Smfish Humans
Spectrometry Nuclear Proteins
Nuclear Proteins
RNA, Viral
RNA, Viral
SARS-CoV-2
Virus Replication

Semantics

Type Source Name
disease IDO replication
drug DRUGBANK Isoxaflutole
disease IDO host
disease IDO process
pathway KEGG Viral replication
disease IDO role
pathway REACTOME Translation
disease IDO protein
disease MESH COVID-19
pathway REACTOME Signal Transduction
disease MESH relapse
disease MESH Syndrome
disease MESH embryonal carcinoma
disease IDO immunodeficiency
disease IDO production
disease IDO site
disease IDO pathogen
disease MESH Infection
drug DRUGBANK Coenzyme M
disease MESH viral infection
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Zinc
drug DRUGBANK Silver
drug DRUGBANK Trypsin
pathway KEGG Spliceosome
pathway KEGG Ribosome
drug DRUGBANK Huperzine B
disease IDO assay
drug DRUGBANK Myricetin
disease IDO cell
disease MESH dissociation
disease IDO nucleic acid
drug DRUGBANK Proline
drug DRUGBANK Biotin
drug DRUGBANK Amino acids
disease MESH point mutations
drug DRUGBANK Serine
drug DRUGBANK L-Arginine
drug DRUGBANK L-Alanine
drug DRUGBANK Streptomycin
drug DRUGBANK Methylergometrine
drug DRUGBANK Aspartame
disease IDO reagent
drug DRUGBANK Ilex paraguariensis leaf
pathway REACTOME Digestion
drug DRUGBANK Amphotericin B
drug DRUGBANK Zoledronic acid
drug DRUGBANK Isopropyl beta-D-thiogalactopyranoside
drug DRUGBANK Glutathione
drug DRUGBANK Trinitrotoluene
drug DRUGBANK L-Leucine
drug DRUGBANK Methionine
drug DRUGBANK Water
drug DRUGBANK Ethanol
drug DRUGBANK Dextran
drug DRUGBANK Tromethamine
drug DRUGBANK Etoperidone
drug DRUGBANK Guanosine
drug DRUGBANK Geneticin
disease MESH Kaposi’s Sarcoma
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)